Exponent, Inc. (EXPO) Given Consensus Rating of “Buy” by Brokerages

Shares of Exponent, Inc. (NASDAQ:EXPO) have been given an average broker rating score of 1.67 (Buy) from the three analysts that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold rating and two have issued a strong buy rating on the company. Exponent’s rating score has improved by 28.3% in the last 90 days as a result of various analysts’ upgrades and downgrades.

Analysts have set a one year consensus target price of $84.00 for the company and are expecting that the company will post $0.62 EPS for the current quarter, according to Zacks. Zacks has also assigned Exponent an industry rank of 133 out of 265 based on the ratings given to its competitors.

A number of brokerages have recently issued reports on EXPO. BidaskClub upgraded Exponent from a “sell” rating to a “hold” rating in a research report on Monday, February 5th. Cantor Fitzgerald restated a “buy” rating and set a $82.00 price objective on shares of Exponent in a research report on Sunday, November 5th. SunTrust Banks raised Exponent from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a research note on Friday, January 26th. Finally, Zacks Investment Research cut Exponent from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, December 19th.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Advisor Group Inc. grew its stake in Exponent by 15.4% during the second quarter. Advisor Group Inc. now owns 2,131 shares of the business services provider’s stock worth $124,000 after purchasing an additional 284 shares during the period. Trexquant Investment LP acquired a new stake in Exponent during the third quarter worth approximately $224,000. Cubist Systematic Strategies LLC acquired a new stake in Exponent during the third quarter worth approximately $242,000. Stifel Financial Corp acquired a new stake in Exponent during the third quarter worth approximately $249,000. Finally, Capital Fund Management S.A. acquired a new stake in Exponent during the fourth quarter worth approximately $277,000. 91.42% of the stock is owned by institutional investors and hedge funds.

Shares of Exponent (NASDAQ:EXPO) traded up $0.40 on Tuesday, hitting $77.80. The stock had a trading volume of 55,610 shares, compared to its average volume of 105,856. Exponent has a 52 week low of $56.95 and a 52 week high of $78.40. The company has a market capitalization of $2,008.10, a P/E ratio of 51.18 and a beta of 0.72.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, February 1st. The business services provider reported $0.47 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.05. Exponent had a return on equity of 17.81% and a net margin of 11.88%. The company had revenue of $82.72 million during the quarter, compared to the consensus estimate of $80.27 million. During the same period last year, the company earned $0.39 earnings per share. The firm’s revenue was up 13.7% compared to the same quarter last year. sell-side analysts anticipate that Exponent will post 2.41 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Friday, March 2nd will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Thursday, March 1st. This represents a $1.04 annualized dividend and a yield of 1.34%. This is a boost from Exponent’s previous quarterly dividend of $0.21. Exponent’s dividend payout ratio (DPR) is currently 55.26%.

COPYRIGHT VIOLATION WARNING: This article was first reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://transcriptdaily.com/2018/02/25/exponent-inc-expo-given-consensus-rating-of-buy-by-brokerages.html.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply